Synthesis of conjugates of β-cyclodextrin with polyamidoamine dendrimers and their molecular inclusion interaction with levofloxacin lactate

Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems—A Pharmaceutical Perspective

Cyclodextrins (CDs) are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits linked by α-1,4 glycosidic bonds. The shape of CD molecules is similar to a truncated cone with a hydrophobic inner cavity and a hydrophilic surface, which allows the formation of inclusion complexes with various molecules. This review article summarises over 200 reports published by the end of 2021 that discuss the complexation of CDs with antibiotics and antibacterial agents, including beta-lactams, tetracyclines, quinolones, macrolides, aminoglycosides, glycopeptides, polypeptides, nitroimidazoles, and oxazolidinones. The review focuses on drug-delivery applications such as improving solubility, modifying the drug-release profile, slowing down the degradation of the drug, improving biological membrane permeability, and enhancing antimicrobial activity. In addition to simple drug/CD combinations, ternary systems with additional auxiliary substances have been described, as well as more sophisticated drug-delivery systems including nanosponges, nanofibres, nanoparticles, microparticles, liposomes, hydrogels, and macromolecules. Depending on the desired properties of the drug product, an accelerated or prolonged dissolution profile can be achieved when combining CD with antibiotics or antimicrobial agents.

A biocompatible poly(amidoamine) (PAMAM) dendrimer octa-substituted with α-cyclodextrin towards the controlled release of doxorubicin hydrochloride from its ferrocenyl prodrug

Facile and efficient methods for the synthesis of the first poly(aminodamine) PAMAM G1.0 dendrimer octa-substituted with α-cyclodextrin and a novel ferrocenyl prodrug of doxorubicin hydrochloride are developed. This vector is non-toxic and can bind the designed ferrocenyl prodrug. It also shows a controlled drug release profile and high cytotoxicity against breast cancer cells (MCF-7), as elucidated by the in vitro biological studies performed with an innovative cell-on-a-chip microfluidic system.

Cyclodextrin-Based Nanosystems as Drug Carriers for Cancer Therapy

BACKGROUND AND OBJECTIVE

Cyclodextrins have been of great interest as excellent candidates for fabricating versatile nano-drug delivery systems due to their commercial availability, easy functionalization, low immunogenicity, biocompatibility and safety. The possibility of reversible inclusion complex formation between cyclodextrins and various guest molecules in association with versatile exclusive properties of cyclodextrins offer a route towards the fabrication of highly sophisticated nanostructures with enormous potential for cancer treatment.

METHODS AND RESULTS

The current review discusses important recent advances in the fabrication and development of cyclodextrin-based nanostructures for cancer therapy. Firstly, the formation of inclusion complexes between cyclodextrin derivatives and anticancer compounds, as well as their application, are summarized. Secondly, the cyclodextrins -based nanosystems including cyclodextrin-containing polymers, cyclodextrin-based supramolecular necklaces, which consist of polyrotaxanes and polypseudorotaxanes and cyclodextrin based hydrogels accompanied by their applications in cancer treatment are highlighted. In the end, the future perspective of this field is discussed.

CONCLUSION

Numerous investigations in this area pave the way for the flourishing of the next generation of nano-therapeutics towards enhanced cancer therapy.

Hydrophilic porous polyimide/β-cyclodextrin composite membranes with enhanced gas separation performance and low dielectric constant

A series of co-polyimide (PI)/modified β-cyclodextrin (β-CD) composites were successfully fabricated from anhydride-terminated PI and (3-aminopropyl)triethoxysilane-modified β-CD (β-ACD). Co-PI was prepared from 4,4′-oxydianiline, 4,4′-(hexafluoroisopropylidene) diphthalic anhydride, and 2,2-bis[4-(3,4-dicarboxyphenoxy)phenyl]propane dianhydride by chemical imidization. Different amounts of β-ACD (0, 1, 3, 5, and 7 wt%) were introduced into co-PI via strong covalent interactions between the terminal anhydride and amino groups. The structures and properties of the composites were characterized by means of Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, thermal gravimetric analysis, differential scanning calorimetry, dynamic thermomechanical analysis, mechanical properties tests, and contact angle tests. The results showed that β-ACD was successfully grafted on the PI segment. The composite films showed good thermal stability, glass transition temperatures between 244°C and 254°C, and 10% weight loss at temperatures of 514°C–545°C and 506°C–538°C in nitrogen and air atmosphere, respectively. They also exhibited excellent mechanical properties with tensile strength, tensile modulus, and elongation at break values of 78–111 MPa, 1.14–2.05 GPa, and 8–17%, respectively. All of these values were maximized at a β-ACD content of 1 wt%. The water uptake of the composites films was more than 1%, indicating that the addition of β-ACD can enhance the water absorption of PI films. All of these composite films are porous, and the contact angle indicated that the addition of β-ACD increased the hydrophilicity of the composite film. When the β-ACD doping content reached 7 wt%, the contact angle reached a minimum of 63°. All of the membranes were thermally annealed at 300°C for 1 h, after which gas adsorption tests showed that the composite films have enhanced CO2/CH4 selectivity, which can reach 12.7 (308 K).

In vivo Raman measurement of levofloxacin lactate in blood using a nanoparticle-coated optical fiber probe

Monitoring drug concentrations in vivo is very useful for adjusting a drug dosage during treatment and for drug research. Specifically, cutting-edge "on-line" drug research relies on knowing how drugs are metabolized or how they interact with the blood in real-time. Thus, this study explored performing in vivo Raman measurements of the model drug levofloxacin lactate in the blood using a nanoparticle-coated optical fiber probe (optical fiber nano-probe). The results show that we were able to measure real-time changes in the blood concentration of levofloxacin lactate, suggesting that this technique could be helpful for performing drug analyses and drug monitoring in a clinical setting without repeatedly withdrawing blood from patients.

Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective

The excellent biocompatibility and unique inclusion capability as well as powerful functionalization capacity of cyclodextrins and their derivatives make them especially attractive for engineering novel functional materials for biomedical applications. There has been increasing interest recently to fabricate supramolecular systems for drug and gene delivery based on cyclodextrin materials. This review focuses on state of the art and recent advances in the construction of cyclodextrin-based assemblies and their applications for controlled drug delivery. First, we introduce cyclodextrin materials utilized for self-assembly. The fabrication technologies of supramolecular systems including nanoplatforms and hydrogels as well as their applications in nanomedicine and pharmaceutical sciences are then highlighted. At the end, the future directions of this field are discussed.